arrow
M

Maciej Kwiatkowski

Cantonal Hospital Aarau
H指数:29
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development and Internal Validation of a Side-Specific Nomogram Integrating mpMRI and Biopsy Features to Guide Nerve-Sparing Decision Making in Prostate Cancer with Capsular Contact

基于mpMRI和活检特征,开发并内部验证用于指导前列腺癌包膜接触患者神经保留决策的侧特异性列线图

Cancers
IF4.4
2026-05-290
OAAI
Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer

前列腺癌检测基线前列腺特异性抗原与前列腺癌死亡之间的关系: 欧洲前列腺癌筛查随机研究的长期随访

2023-11-0113
OA
A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guerin (BCG) VPM1002BC Immunotherapy in Non- muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14

重组卡介苗 (BCG) VPM1002BC免疫治疗常规卡介苗治疗后非肌肉浸润性膀胱癌复发的1/2期单臂临床试验: SAKK 06/14

2022-04-0116
PRE
A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

欧洲前列腺癌筛查随机研究的16年随访

2019-07-01413
OAAI
The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials
CANCER
IF5.1
2017-12-0652
OAAI
Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials
2017-10-03178
OAAI
GERMLINE MUTATIONS IN THE KALLIKREIN 6 REGION AND PREDISPOSITION FOR AGGRESSIVE PROSTATE CANCER
2017-04-010
OAAI
Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer
2017-03-147
OAAI